Today

Agents

Chat

Arena

Discover

More

App

Protalix BioTherapeutics Q2 Pretax Profit USD 4.86 Million - PLX News | Rallies

Protalix BioTherapeutics Q2 Pretax Profit USD 4.86 Million

PLX•2026-08-12

Q2 pretax profit

Aug. 12 (Reuters) - Protalix BioTherapeutics Q2 pretax profit was USD 4.86 million.

Additional Q2 figures

Q2 operating income: USD 4.672 million
Q2 net income: USD 3.777 million

Related News

Local Bounti Q2 revenue rises on higher production and sales

LOCL•2026-08-12

Local Bounti Q2 FY26 net loss narrows 8.15% to 19.82 million; sales rise 14% to 13.85 million

LOCL•2026-08-12

Avino Q2 FY26 net income more than doubled to US$10.9 million; revenue rises 23% to US$26.8 million

ASM

•

2026-08-12

Vor Biopharma Inc. <VOR.O>: Wedbush raises target price to $27 from $18

VOR•2026-08-12

Prader-Willi experts flag safety risks linked to Neurocrine's rare disease drug

NBIX•2026-08-12